Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
AU565
HER2amp
Luminal
Fascaplysin
CDK4
CDK
5901.084
uM
0.08674
0.20069
-0.9407 -0.9232 1.2470 0.7548
0.9992
1.7402
SUM149PT
TNBC
Basal B
Bortezomib
Proteasome
Proteasome
7530.074
uM
0.05589
0.08823
-0.8823 -0.8633 2.1969 1.0962
0.9992
2.0964
HCC1428
HR+
Luminal
Trichostatin A
HDAC
HDAC
7444.065
uM
1.45170
2.67320
-0.9873 -0.9919 1.7904 1.1581
0.9992
0.7419
SK-BR-3
HER2amp
Luminal
Bortezomib
Proteasome
Proteasome
15327.203
uM
0.00180
0.00383
-0.8066 -0.7982 1.2648 1.3619
0.9992
0.9247
SK-BR-3
HER2amp
Luminal
Bortezomib
Proteasome
Proteasome
15327.203
uM
0.00180
0.00383
-0.8066 -0.7982 1.2648 1.3619
0.9992
0.9247
HCC1187
TNBC
Basal A
Cisplatin
DNA cross-linker
DNA cross-linker
7812.017
uM
3.44630
6.68930
-0.9960 -1.0000 1.6565 0.5582
0.9992
1.1362
MX1
Unknown
Unknown
MG-132
Proteasome
Proteasome
10644.145
uM
0.04734
0.07256
-1.0000 -1.0000 2.5730 1.0527
0.9991
0.4300
HCC1937
TNBC
Basal A
MG-132
Proteasome
Proteasome
11849.145
uM
0.13365
0.16967
-0.8677 -0.8553 4.1787 0.8372
0.9991
1.5253
HCC1143
TNBC
Basal A
IKK16
IKK
NFKB
7430.093
uM
3.9730
4.84760
-0.8497 -0.8522 5.0000 0.3517
0.9991
1.9432
MX1
Unknown
Unknown
MG-132
Proteasome
Proteasome
10644.145
uM
0.04734
0.07256
-1.0000 -1.0000 2.5730 1.0527
0.9991
0.4300
HCC70
TNBC
Basal A
Taxol
TUBB
TUBB
12714.002
uM
0.00853
0.01048
-0.9148 -0.9050 5.0000 1.1860
0.9991
0.4328
MDA-MB-361
HER2amp
Luminal
Torkinib
15396.211
uM
0.00334
0.01326
-0.6071 -0.6008 0.5726 1.0084
0.9991
0.9137
HCC38
TNBC
Basal B
MG-132
Proteasome
Proteasome
11850.145
uM
0.18684
0.24135
-0.7584 -0.7476 3.5716 0.7743
0.9991
2.1492
MCF 10A
NM
Basal B
Sunitinib
PDGFR/VEGFR/KIT/FLT3
RTK
7483.067
uM
7.35150
12.33760
-0.7295 -0.7449 1.7619 0.3474
0.9991
3.2893
HCC1937
TNBC
Basal A
MG-132
Proteasome
Proteasome
11849.145
uM
0.13365
0.16967
-0.8677 -0.8553 4.1787 0.8372
0.9991
1.5253
MDA-MB-415
HR+
Luminal
Fascaplysin
CDK4
CDK
7512.084
uM
0.05608
0.07520
-0.9999 -0.9952 3.7340 0.9064
0.9991
0.7511
AU565
HER2amp
Luminal
Topotecan
TOP1
TOP
7793.007
uM
0.00691
0.01211
-0.7351 -0.7087 1.5714 1.2066
0.9991
1.3832
HBL-100
Unknown
Unknown
Sorafenib
PDGFR/VEGFR/KIT/FLT3
RTK
7429.084
uM
48.25460
66.54960
-0.7786 -0.7812 2.9272 0.3710
0.9991
2.2510
HCC38
TNBC
Basal B
Gemcitabine
DNA replication
DNA replication
9028.075
uM
0.00457
0.00564
-0.9576 -0.9350 5.0000 1.7932
0.9991
0.6011
MDA-MB-361
HER2amp
Luminal
17-AAG
HSP90
HSP90
9648.037
uM
0.03015
0.0370
-0.9033 -0.8903 5.0000 1.1329
0.9991
0.6971
HCC38
TNBC
Basal B
MG-132
Proteasome
Proteasome
11850.145
uM
0.18684
0.24135
-0.7584 -0.7476 3.5716 0.7743
0.9991
2.1492
HCC3153
TNBC
Basal A
NSC 663284
CDC25
CDC
10577.14
uM
2.4650
3.61860
-0.9817 -0.9832 2.8326 0.5933
0.9991
0.9722
HCC1937
TNBC
Basal A
Fascaplysin
CDK4
CDK
7452.084
uM
0.36891
0.53806
-0.9076 -0.8914 2.7117 0.6139
0.9991
1.6800
HCC70
TNBC
Basal A
Cisplatin
DNA cross-linker
DNA cross-linker
7857.017
uM
1.60450
2.36240
-0.9732 -0.9789 2.8032 0.7284
0.9991
1.1840
Hs 578T
TNBC
Basal B
Oxamflatin
HDAC
HDAC
10694.147
uM
1.63690
3.29360
-0.6479 -0.6730 1.2196 0.3912
0.9991
2.3818